Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPECULATE: Amiodarone in LSP AF Ablation
NCT01173809Phase 3Completed
- Sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Start
- Oct 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Texas Cardiac Arrhythmia Research Foundation. Primary endpoint: Recurrence of AF, atrial flutter or atrial tachycardia at 1 year. Started Oct 2010; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01173809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173809.